EEG/MECG/EMG Evaluating the Severity of Aortic Stenosis, Heart Failure and Ischemic Stroke Through an Artificial Intelligenceassisted System.

Not yet recruiting

• Conditions: CVD

• Registration Number: NCT05716659
• Lead Sponsor: National Taiwan University Hospital

Brief Summary

The specific objectives and methods of this project are: (1) To test the feasibility and accuracy of integrating EEG, MECG and EMG for detecting the severity of diseases such as aortic stenosis, heart failure and ischemic stroke. (2) Improve the accuracy of this multi-channel brain-heart-muscle device by using an artificial intelligence auxiliary system. (3) Provide tailor-made interdisciplinary treatment strategies for patients with different disease states.

Detailed Description

Not available

Basic Information
|
Recruitment & Eligibility
|
Study & Design
|
Trial Locations

Study Timeline

• Status Verified: 2022-12
• Study First Submitted: 2023-01-29
• Study First Submitted QC: 2023-01-29
• Study First Posted: 2023-02-08
• Last Update Submitted: 2023-04-06
• Last Update Posted: 2023-04-10
• Study Start: 2023-05-30
• Primary Completion: 2032-07-31
• Study Completion: 2032-08-31

Recruitment & Eligibility

• Status: NOT_YET_RECRUITING
• Sex: All
• Target Recruitment: 750

Inclusion Criteria

Not provided

Read More

Exclusion Criteria

Not provided

Read More

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Composite cardiovascular outcome	up to 10 years	Composite endpoint: Major adverse cardiac events (MACE): myocardial infarction, stroke, hospitalization for heart failure, or cardiovascular death)

Trial Locations

Locations (1)

NTUH; 🇨🇳 Taipei, Taiwan